Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabet

george jacob · 02-13-2008, 06:28 PM

Diamyd Medical (NASDAQ

MYDY) (STO

IAMB) announced that it has received one FDA question relating to the US Phase III IND application for Diamyd® in treatment of type 1 diabetes. The question has been answered with additional documentation and the FDA now has 30 days to respond.

for more info, visit:
Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabetes Study In The US

02-13-2008, 06:28 PM	#1 (permalink)
george jacob Member Join Date: Feb 2008 Posts: 34	Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabet Diamyd Medical (NASDAQMYDY) (STOIAMB) announced that it has received one FDA question relating to the US Phase III IND application for Diamyd® in treatment of type 1 diabetes. The question has been answered with additional documentation and the FDA now has 30 days to respond. for more info, visit: Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabetes Study In The US

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode